Page 4 - Flurotech Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FluroTech” or the “ Company“), a leading developer of spectroscopy-based technology, is pleased to announce it has received conditional approval from the TSX Venture Exchange (the “ Exchange“) to commence an Early Warrant Exercise Incentive Program (“ EWEIP“) intended to encourage the early exercise of up to 18,550,000 Warrants (as defined and described below). In January of 2021, FluroTech closed, in two tranches, a non-brokered private placement of units (“ Units“), for aggregate gross proceeds of $2,531,000. Each Unit comprised one common share in the capital of FluroTech...

Cautionary Statement Regarding Forward-Looking Information This news release contains “forward-looking information” within the meaning of Canadian securities legislation. Forward-looking information generally refers to information about an issuer’s business, capital, technology or operations that is prospective in nature, and includes future-oriented financial information about the issuer’s perspective financial performance or financial position. The forward-looking information in this news release includes disclosure about the ability of the Company’s testing devices to accurately ...

CALGARY, Alberta, March 04, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with joint venture FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, are pleased to announce that an agreement with Toolbox Medical Innovations (“Toolbox”) has been signed this week to carry out clinical trials of the FluroTest pandemic response platform alongside a co...

CALGARY, Alberta, Feb. 19, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with joint venture FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announced that pre-production development of three functioning pandemic defense platform systems are now underway with laboratory robotics automation partner, Hudson Robotics. These units will be used to pilot...

TSXV: OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that is has engaged Venture Liquidity Providers Inc. (“VLP”), subject to regulatory approval, to provide market-making services for the purpose of maintaining an orderly trading market and improving the liquidity of the Company’s shares. The market-making service will be undertaken by VLP through a registered broker, W.D. Latimer Co. Ltd., in compliance with the applicable policies of the TSX Venture Exchange and other applicable laws. For its services, the corporation has agreed to pay VLP $5,000 per m...